Wednesday, October 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

A Turning Point for ASML? UBS Upgrade Sparks Optimism for the Chip Sector Giant

Robert Sasse by Robert Sasse
September 5, 2025
in Analysis, European Markets, Semiconductors, Turnaround
0
ASML Stock
0
SHARES
124
VIEWS
Share on FacebookShare on Twitter

After navigating a challenging period, Dutch semiconductor equipment manufacturer ASML is showing signs of a potential recovery. In a notable shift, UBS has upgraded its rating on the company’s shares from “Neutral” to “Buy,” a move that follows a year where the stock declined by 20%. This bullish stance from the Swiss bank, which arrives amid lingering skepticism from other analysts, suggests the worst of the downturn may be over.

The upgrade is anchored on the belief that all known headwinds are now fully reflected in the share price. According to UBS analyst Francois-Xavier Bouvignies, concerns over weaker demand for lithography systems and ongoing uncertainties related to the Chinese market are already priced in.

UBS has set a new price target of 750 euros, a significant increase from its previous target of 660 euros. The bank’s forward-looking analysis is particularly striking, as it forecasts that ASML will achieve annual profit growth of 20 percent between 2026 and 2030. This projected acceleration is tied to imminent technological advancements in the chip industry.

Should investors sell immediately? Or is it worth buying ASML?

Two key developments are expected to be major catalysts. First, the new A14 processor node from TSMC is anticipated to drive renewed demand for ASML’s extreme ultraviolet (EUV) lithography systems. Second, the company’s groundbreaking next-generation High-NA EUV technology is on the verge of a commercial breakthrough. By the end of the decade, these advanced machines could contribute 15 to 20 percent of total company revenue, highlighting the immense growth potential for this monopolist in cutting-edge chip manufacturing.

However, this optimistic view is not universally shared. Other financial institutions have recently expressed caution. On September 2, Bank of America reduced its price target, citing macroeconomic uncertainties and potential tariff risks, with particular concern over sluggish demand from China. Similarly, both Erste Group and Freedom Broker have recently downgraded their ratings to “Hold.”

The upcoming quarterly report on October 15 is poised to be a critical test for these competing viewpoints. When ASML releases its third-quarter earnings, it will provide crucial insights into its current order book. While company management has thus far reaffirmed its full-year revenue guidance of 30 to 35 billion euros, investors are expected to scrutinize every detail of the report for clues about the company’s trajectory amidst conflicting market signals.

Ad

ASML Stock: Buy or Sell?! New ASML Analysis from October 22 delivers the answer:

The latest ASML figures speak for themselves: Urgent action needed for ASML investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

ASML: Buy or sell? Read more here...

Tags: ASML
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Unitedhealth Stock
AI & Quantum Computing

UnitedHealth Faces Legal and Technological Crossroads

October 22, 2025
Commerzbank Stock
Analysis

Commerzbank Unleashes Billion-Euro Share Buyback Program

October 21, 2025
Infineon Stock
Analysis

Infineon Shares: The Struggle for Market Momentum

October 21, 2025
Next Post
AMD Stock

AMD's High-Stakes Balancing Act in the AI Boom

Apple Stock

Apple Stock Receives Major Boost from Court Victory and Emerging Market Surge

BioNTech Stock

BioNTech Achieves Major Oncology Breakthrough with Phase 3 Cancer Trial Success

Recommended

Porsche Holding Stock

Porsche’s Electric Vehicle Strategy Stalls, Sending Shockwaves Through Volkswagen Group

3 weeks ago
Johnson & Johnson Stock

Johnson & Johnson Bolsters US Operations and Delivers Reliable Returns

2 months ago
Tesla Stock

Tesla’s Strategic Pivot Faces Investor Scrutiny

2 weeks ago
Entertainment Markets and money (1)

Mark Wahlberg From Hollywood Success to Business Mogul

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Commerzbank Unleashes Billion-Euro Share Buyback Program

Infineon Shares: The Struggle for Market Momentum

Strategic Partnership with Glencore Marks Turning Point for Vulcan Energy

Nel ASA Faces Severe Headwinds as Order Intake Plummets

Defense Stock Rebounds: Hensoldt Shares Stage Impressive Recovery

BlackRock Adjusts Position in Puma, Signaling Potential Shift for Struggling Sportswear Giant

Trending

Unitedhealth Stock
AI & Quantum Computing

UnitedHealth Faces Legal and Technological Crossroads

by Dieter Jaworski
October 22, 2025
0

As UnitedHealth Group prepares to release its third-quarter earnings, the healthcare giant finds itself navigating turbulent waters....

Summit Materials Stock

Summit Materials Shares Cease Trading Following Acquisition

October 22, 2025
DroneShield Stock

DroneShield Shares Surge on Exceptional Quarterly Performance

October 21, 2025
Commerzbank Stock

Commerzbank Unleashes Billion-Euro Share Buyback Program

October 21, 2025
Infineon Stock

Infineon Shares: The Struggle for Market Momentum

October 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Faces Legal and Technological Crossroads
  • Summit Materials Shares Cease Trading Following Acquisition
  • DroneShield Shares Surge on Exceptional Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com